Following a national search, Roswell Park Comprehensive Cancer Center has appointed Marco Davila, MD, PhD, as Senior Vice President and Associate Director for Translational Research and Vice-Chair for Cellular Therapies.
With a breast cancer patient facing limited options for reconstructive surgery after her body rejected breast implants, Wong Moon, MD, FACS, Associate Professor of Oncology at Roswell Park Comprehensive Cancer Center, found an innovative ...
Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery at Roswell Park Comprehensive Cancer Center shares the newest innovations of breast cancer treatment at Roswell Park and why to choose Roswell Park for your patient’s care.
A screening clinical trial underway at Roswell Park Comprehensive Cancer Center and other centers across the U.S. will take the next step toward determining the effectiveness of cancer treatments informed by genomic sequencing of the tumor.
Findings point to features of therapeutic response and potential biomarkers
A team at Roswell Park Comprehensive Cancer Center has uncovered a link between survival and the number of tumor-infiltrating lymphocytes (TILs) in the tumors of breast cancer patients.
A large retrospective study conducted by physician researchers from Roswell Park Comprehensive Cancer Center reports benefits of chemotherapy for many patients with early-stage breast cancer with rare variant histology, or tumor anatomy.
Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, ...
A research team headed by Roswell Park Comprehensive Cancer Center epidemiologist Zhihong Gong, PhD, has been awarded a five-year, $1.9 million grant from the National Cancer Institute for an investigation into the role that certain genetic ...
This site is intended for healthcare professionals